Levrevo, M. et al, 1990, Gene, pp. 195-202. |
K. Charlton et al, "Oral Rabies Vaccination of Skunks and Foxes with a Recombinant Human Adenovirus Vaccine", Arch. Virol., 123:169-179 (1992). |
D. Johnson et al, "Abundant Expression of Herpes Simplex Virus Glycoprotein gb Using an Adenovirus Vector", Virology, 164:1-14 (1988). |
R. Dewar et al, "Synthesis and Processing of Human Immunodeficiency Virus type 1 Envelope Proteins Encoded by a Recombinant Human Adenovirus", J. Virol., 63(1):129-136 (Jan., 1989). |
B. Brochier et al, "Towards Rabies Elimination in Belgium by Fox Vaccination Using a Vaccinia-Rabies Glycoprotein Recombinant Virus", Vaccine, 12(15):1368-1371 (Nov., 1994). |
L. Prevec et al, "A Recombinant Human Adenovirus Vaccine Against Rabies", J. Infect. Dis., 161:27-30 (Jan., 1990). |
K. Kozarsky et al, "In Vivo Correction of Low Density Lipoprotein Receptor Deficiency in the Watanabe Heritable Hyperlipidemic Rabbit with Recombinant Adenoviruses", J. Biol. Chem., 269(18):13695-13702 (May 6, 1994) �Kozarsky I!. |
K. Kozarsky et al, "Adenovirus-Mediated Correction of the Genetic Defect in Hepatocytes from Patients with Familial Hypercholesterolemia", Somatic Cell and Molecular Genetics, 19(5):449-458 (Sep., 1993) �Kozarsky II!. |
K. Kozarsky et al, "Gene Therapy: Adenovirus Vectors", Curr. Opin. Genet. Devel., 3:499-503 (Mar., 1993) �Kozarsky III!. |
Y. Yang et al, "MHC Class I-Restricted Cytotoxic T Lymphocytes to Viral Antigens Destroy Hepatocytes in Mice Infected with E1-Deleted Recombinant Adenoviruses", Immunity, 1:433-442 (Aug., 1994) �Yang I!. |
Y. Yang et al, "Cellular Immunity to Viral Antigens Limits E1-Deleted Adenoviruses for Gene Therapy", Proc. Natl. Acad. Sci. USA, 91:4407-4411 (May, 1994) �Yang II!. |
Y. Yang et al, "Inactivation of E2a in Recombinant Adenoviruses Improves the Prospect for Gene Therapy in Cystic Fibrosis", Nature Genetics, 7:362-369 (Jul., 1994) �Yang III!. |
S. Ishibashi et al, "Hypercholesterolemia in Low Density Lipoprotein Receptor Knockout Mice and its Reversal by Adenovirus-Mediated Gene Delivery", J. Clin. Invest., 92:883-893 (Aug., 1993). |
J. Engelhardt et al, "Ablation of E2A in Recombinant Adenoviruses Improves Transgene Persistence and Decreases Inflammatory Response in Mouse Liver", Proc. Natl. Acad. Sci. USA, 91:6196-6200 (Jun., 1994) �Engelhardt I!. |
J. Engelhardt et al, "Adenovirus-Mediated Transfer of the CFTR Gene to Lung of Nonhuman Primates: Biological Efficacy Study", Human Genet. Ther., 4:759-769 (Dec., 1993) �Engelhardt II!. |
J. Engelhardt et al, "Prolonged Transgene Expression in Cotton Rat Lung with Recombinant Adenoviruses Defective in E2a", Human Gene Ther., 5:1217-1229 (Oct., 1994) �Engelhardt III!. |
M Horwitz, "Adenoviridae and Their Replication", Virology, 2d edition, ed. B. N. Fields, Raven Press, Ltd., New York, Chapter 60, pp. 1679-1721 (1990). |
M. Boshart et al, "A Very Strong Enhancer is Located Upstream of an Immediate Early Gene of Human Cytomegalovirus", Cell, 41:521-530 (Jun., 1985). |
K. Fisher et al, "Biochemical and Functional Analysis of an Adenovirus-Based Ligand Complex for Gene Transfer", Biochem. J., 299:49-58 (Apr. 1, 1994). |
T. Shenk et al, "Genetic Analysis of Adenoviruses", Current Topics in Microbiol. and Immunol., 111:1-39 (1984). |
M. Rosenfeld et al, "In Vivo Transfer of the Human Cystic Fibrosis Transmembrane Conductance Regulator Gene to the Airway Epithelium", Cell, 68:143-155 (Jan. 10, 1992). |
J. Logan et al, "Adenovirus Tripartite Leader Sequence Enhances Translation of mRNAs Late After Infection", Proc. Natl. Acad. Sci. USA, 81:3655-3659 (Jun., 1984). |
P. Van Der Vliet et al, "Thermolabile DNA Binding Proteins from Cells Infected with a Temperature-Sensitive Mutant of Adenovirus Defective in Viral DNA Synthesis", J. Virol., 15(2):348-354 (Feb., 1975). |
M. Eloit et al, "Construction of a Defective Adenovirus Vector Expressing the Pseudorabies Virus Glycoprotein gp50 and its Use as a Live Vaccine", J. Gen. Virol., 71(10):2425-2431 (Oct., 1990). |
S. Jacobs et al, "High-Level Expression of the Tick-Borne Encephalitis Virus NS1 Protein by Using an Adenovirus-based Vector: Protection Elicited in a Murine Model", J. Virol., 66:2086-2095 (Apr., 1992). |
T. Ragot et al, "Replication-Defective Recombinant Adenovirus Expressing the Epstein-Barr Virus (EBV) Envelope Glycoprotein gp340/220 Induces Protective Immunity Against EBV-induced Lymphomas in the Cottontop Tamarin", J. Gen. Virol., 74(3):501-507 (Mar., 1993). |